Cellebrite DI Ltd. (CLBT)
NASDAQ: CLBT · Real-Time Price · USD
21.01
0.00 (0.00%)
Dec 5, 2024, 1:05 PM EST - Market open
Cellebrite DI Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Revenue | 385.17 | 325.11 | 270.65 | 246.25 | 194.91 | 171.85 |
Revenue Growth (YoY) | 25.82% | 20.12% | 9.91% | 26.34% | 13.42% | - |
Cost of Revenue | 59.89 | 53.23 | 50.75 | 42.56 | 37.88 | 35.82 |
Gross Profit | 325.28 | 271.88 | 219.91 | 203.69 | 157.03 | 136.03 |
Selling, General & Admin | 174.54 | 154.26 | 138.24 | 124.33 | 91.59 | 90.98 |
Research & Development | 94.57 | 84.39 | 80.62 | 65.54 | 54.38 | 46.57 |
Operating Expenses | 269.1 | 238.64 | 218.86 | 189.87 | 145.97 | 137.55 |
Operating Income | 56.18 | 33.24 | 1.04 | 13.82 | 11.07 | -1.52 |
Interest & Investment Income | 8.89 | 8.89 | 1.6 | 0.85 | 2.71 | 3.48 |
Currency Exchange Gain (Loss) | 0.21 | 0.21 | 0.85 | -0.19 | -0.45 | -0.19 |
Other Non Operating Income (Expenses) | -117.89 | -117.89 | 117.27 | 67.83 | -0.09 | -0.35 |
EBT Excluding Unusual Items | -308.23 | -75.56 | 120.76 | 82.31 | 13.25 | 1.42 |
Merger & Restructuring Charges | - | - | - | - | -1.85 | - |
Pretax Income | -308.23 | -75.56 | 120.76 | 82.31 | 11.4 | 1.42 |
Income Tax Expense | 8.7 | 5.54 | -0.05 | 10.91 | 5.62 | 3.29 |
Net Income | -316.92 | -81.1 | 120.81 | 71.4 | 5.78 | -1.88 |
Preferred Dividends & Other Adjustments | - | - | 4.69 | 0.96 | 15.13 | 8.16 |
Net Income to Common | -316.92 | -81.1 | 116.11 | 70.43 | -9.34 | -10.04 |
Net Income Growth | - | - | 69.20% | 1135.01% | - | - |
Shares Outstanding (Basic) | 200 | 190 | 183 | 144 | 124 | 122 |
Shares Outstanding (Diluted) | 200 | 190 | 195 | 162 | 124 | 122 |
Shares Change (YoY) | 6.38% | -2.68% | 20.96% | 30.59% | 1.76% | - |
EPS (Basic) | -1.59 | -0.43 | 0.64 | 0.49 | -0.08 | -0.08 |
EPS (Diluted) | -1.59 | -0.43 | 0.59 | 0.44 | -0.08 | -0.08 |
EPS Growth | - | - | 34.09% | - | - | - |
Free Cash Flow | 102.38 | 96.83 | 13.68 | 30.94 | 60.33 | 9.92 |
Free Cash Flow Per Share | 0.51 | 0.51 | 0.07 | 0.19 | 0.49 | 0.08 |
Gross Margin | 84.45% | 83.63% | 81.25% | 82.72% | 80.57% | 79.15% |
Operating Margin | 14.59% | 10.22% | 0.39% | 5.61% | 5.68% | -0.88% |
Profit Margin | -82.28% | -24.95% | 42.90% | 28.60% | -4.79% | -5.84% |
Free Cash Flow Margin | 26.58% | 29.78% | 5.05% | 12.57% | 30.95% | 5.77% |
EBITDA | 67.17 | 43.74 | 10.73 | 20.9 | 16.95 | 2.56 |
EBITDA Margin | 17.44% | 13.46% | 3.97% | 8.49% | 8.69% | 1.49% |
D&A For EBITDA | 10.99 | 10.51 | 9.69 | 7.07 | 5.88 | 4.08 |
EBIT | 56.18 | 33.24 | 1.04 | 13.82 | 11.07 | -1.52 |
EBIT Margin | 14.59% | 10.22% | 0.39% | 5.61% | 5.68% | -0.88% |
Effective Tax Rate | - | - | - | 13.25% | 49.28% | 232.58% |
Revenue as Reported | 385.17 | 325.11 | 270.65 | 246.25 | 194.91 | 171.85 |
Source: S&P Capital IQ. Standard template. Financial Sources.